
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8509108
[patent_doc_number] => 20120308516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'USE OF METALLOCENE COMPOUNDS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/488490
[patent_app_country] => US
[patent_app_date] => 2012-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/488490 | Use of metallocene compounds for cancer treatment | Jun 4, 2012 | Issued |
Array
(
[id] => 8503165
[patent_doc_number] => 20120302573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 13/479421
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27871
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/479421 | METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION | May 23, 2012 | Abandoned |
Array
(
[id] => 8381477
[patent_doc_number] => 20120225103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'Transdermal Therapeutic System Containing a Pramipexol Active Agent'
[patent_app_type] => utility
[patent_app_number] => 13/473724
[patent_app_country] => US
[patent_app_date] => 2012-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3315
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473724
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473724 | Transdermal Therapeutic System Containing a Pramipexol Active Agent | May 16, 2012 | Abandoned |
Array
(
[id] => 11486173
[patent_doc_number] => 09592236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Methods of treating hemoglobinopathies'
[patent_app_type] => utility
[patent_app_number] => 14/114456
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 47
[patent_no_of_words] => 24015
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114456
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114456 | Methods of treating hemoglobinopathies | Apr 29, 2012 | Issued |
Array
(
[id] => 8510393
[patent_doc_number] => 20120309801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'CALIXARENE-BASED PEPTIDE CONFORMATION MIMETICS, METHODS OF USE, AND METHODS OF MAKING'
[patent_app_type] => utility
[patent_app_number] => 13/454525
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32104
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454525
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454525 | Calixarene-based peptide conformation mimetics, methods of use, and methods of making | Apr 23, 2012 | Issued |
Array
(
[id] => 9503575
[patent_doc_number] => 08741889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/450629
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17643
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450629 | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor | Apr 18, 2012 | Issued |
Array
(
[id] => 9552050
[patent_doc_number] => 08759097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Inhibition of dynamin related protein 1 to promote cell death'
[patent_app_type] => utility
[patent_app_number] => 13/450345
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 14344
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450345
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450345 | Inhibition of dynamin related protein 1 to promote cell death | Apr 17, 2012 | Issued |
Array
(
[id] => 8442401
[patent_doc_number] => 20120259017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Use of Propionic Acid as an Antimicrobial'
[patent_app_type] => utility
[patent_app_number] => 13/444037
[patent_app_country] => US
[patent_app_date] => 2012-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6526
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13444037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/444037 | Use of Propionic Acid as an Antimicrobial | Apr 10, 2012 | Abandoned |
Array
(
[id] => 9408994
[patent_doc_number] => 20140100246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATENTS'
[patent_app_type] => utility
[patent_app_number] => 14/111211
[patent_app_country] => US
[patent_app_date] => 2012-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3153
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111211
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111211 | ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATENTS | Apr 10, 2012 | Abandoned |
Array
(
[id] => 8442323
[patent_doc_number] => 20120258937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Targeting Estrogen Receptors in the Treatment of Lymphangioleiomyomatosis'
[patent_app_type] => utility
[patent_app_number] => 13/442249
[patent_app_country] => US
[patent_app_date] => 2012-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7565
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442249
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/442249 | Targeting Estrogen Receptors in the Treatment of Lymphangioleiomyomatosis | Apr 8, 2012 | Abandoned |
Array
(
[id] => 8896697
[patent_doc_number] => 08476218
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-07-02
[patent_title] => 'Antimicrobial compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 13/442018
[patent_app_country] => US
[patent_app_date] => 2012-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2663
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442018
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/442018 | Antimicrobial compositions and related methods | Apr 8, 2012 | Issued |
Array
(
[id] => 8441564
[patent_doc_number] => 20120258180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'PARP INHIBITORS FOR THE TREATMENT OF CIPN'
[patent_app_type] => utility
[patent_app_number] => 13/442294
[patent_app_country] => US
[patent_app_date] => 2012-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9595
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442294
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/442294 | PARP INHIBITORS FOR THE TREATMENT OF CIPN | Apr 8, 2012 | Abandoned |
Array
(
[id] => 8430980
[patent_doc_number] => 20120252853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Positive allosteric modulators of nicotinic acetylcholine receptor'
[patent_app_type] => utility
[patent_app_number] => 13/434884
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34761
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434884
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/434884 | Positive allosteric modulators of nicotinic acetylcholine receptor | Mar 29, 2012 | Abandoned |
Array
(
[id] => 8431018
[patent_doc_number] => 20120252894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'COMPOUNDS FOR ALLEVIATING PAIN AND STRESS IN FETUS AND NEWBORN'
[patent_app_type] => utility
[patent_app_number] => 13/435522
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7725
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435522
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/435522 | COMPOUNDS FOR ALLEVIATING PAIN AND STRESS IN FETUS AND NEWBORN | Mar 29, 2012 | Abandoned |
Array
(
[id] => 13916555
[patent_doc_number] => 10202385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines
[patent_app_type] => utility
[patent_app_number] => 14/009751
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27175
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009751
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009751 | Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines | Mar 28, 2012 | Issued |
Array
(
[id] => 8429755
[patent_doc_number] => 20120251630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'REMISSION THERAPY OF CANCER WITH ISOFLAVONOIDS'
[patent_app_type] => utility
[patent_app_number] => 13/434665
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10635
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/434665 | REMISSION THERAPY OF CANCER WITH ISOFLAVONOIDS | Mar 28, 2012 | Abandoned |
Array
(
[id] => 12621477
[patent_doc_number] => 20180098989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => FLUOROURACIL GLYCOLATE A NEW COMPOUND IN THE TREATMENT OF WARTS, MOLLUSCUM CONTAGIOSUM: MAGIC WART CREAM
[patent_app_type] => utility
[patent_app_number] => 13/506097
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506097
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/506097 | Fluorouracil glycolate compound for the treatment of warts, molluscum contagiosum | Mar 25, 2012 | Issued |
Array
(
[id] => 8289299
[patent_doc_number] => 20120177624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT'
[patent_app_type] => utility
[patent_app_number] => 13/427242
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8202
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13427242
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/427242 | ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT | Mar 21, 2012 | Abandoned |
Array
(
[id] => 8660151
[patent_doc_number] => 20130040979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'CCR1 INHIBITORS USEFUL FOR THE TREAMENT OF MULTIPLE MYELOMA AND OTHER DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/423447
[patent_app_country] => US
[patent_app_date] => 2012-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14896
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423447
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/423447 | CCR1 INHIBITORS USEFUL FOR THE TREAMENT OF MULTIPLE MYELOMA AND OTHER DISORDERS | Mar 18, 2012 | Abandoned |
Array
(
[id] => 8490163
[patent_doc_number] => 20120289570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CANCER BY INHIBITING FATTY ACID BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/422712
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 22340
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422712
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/422712 | Methods for treating ovarian cancer by inhibiting fatty acid binding proteins | Mar 15, 2012 | Issued |